What is the antibiotic of choice for a 13‑year‑old male with Henoch‑Schönlein purpura who also has streptococcal tonsillitis?

Antibiotic of Choice for Streptococcal Tonsillitis in a 13‑Year‑Old with Henoch‑Schönlein Purpura

For a 13‑year‑old male with confirmed streptococcal tonsillitis and concurrent Henoch‑Schönlein purpura, prescribe oral amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for a full 10‑day course. 1, 2

Rationale for Amoxicillin as First‑Line Therapy

• Zero documented penicillin resistance exists worldwide among Group A Streptococcus, guaranteeing reliable bacterial eradication regardless of the patient's underlying vasculitis. 1, 2
• Amoxicillin demonstrates proven efficacy in preventing acute rheumatic fever, the primary therapeutic goal when treating streptococcal pharyngitis, and this goal remains unchanged by the presence of HSP. 1, 2
• The narrow antimicrobial spectrum of amoxicillin minimizes disruption of normal flora and reduces selection pressure for resistant organisms, which is particularly important in a child with an autoimmune condition. 1, 2
• Amoxicillin offers better palatability and more convenient twice‑daily dosing compared with penicillin V's 2–3‑times‑daily regimen, improving adherence in adolescents. 1, 2

HSP Does Not Alter Antibiotic Selection

• Henoch‑Schönlein purpura is an IgA‑mediated autoimmune hypersensitivity vasculitis often associated with Group A Streptococcus infection, but the presence of HSP does not contraindicate standard antibiotic therapy for concurrent strep throat. 3
• Treatment of the streptococcal infection should proceed with standard first‑line antibiotics; there is no evidence that HSP requires modification of antibiotic choice, dose, or duration. 3
• The vasculitis itself is managed supportively with close monitoring of renal function, but eradicating the streptococcal trigger with appropriate antibiotics is a critical component of overall management. 3

Mandatory 10‑Day Treatment Duration

• A complete 10‑day course is essential to achieve maximal pharyngeal eradication of Group A Streptococcus and to prevent acute rheumatic fever, even if symptoms improve within 3–4 days. 1, 2
• Shortening the course by even a few days markedly increases treatment‑failure rates and the risk of acute rheumatic fever, which could compound the patient's existing autoimmune condition. 1, 2
• The primary therapeutic objective is prevention of acute rheumatic fever and suppurative complications, not merely symptom relief, making the full 10‑day duration non‑negotiable. 1, 2

Alternative Regimens for Penicillin Allergy

Non‑Immediate (Delayed) Penicillin Allergy

• First‑generation cephalosporins (e.g., cephalexin 20 mg/kg twice daily, maximum 500 mg per dose) for 10 days are preferred, with a cross‑reactivity risk of only 0.1%. 1, 2

Immediate/Anaphylactic Penicillin Allergy

• Clindamycin 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days is the preferred alternative, with only ~1% resistance among U.S. Group A Streptococcus isolates and superior eradication even in chronic carriers. 1, 2
• Azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days is an acceptable alternative, but macrolide resistance in the United States ranges from 5–8%, making it less reliable than clindamycin. 1, 2
• All β‑lactam antibiotics must be avoided in patients with immediate/anaphylactic penicillin reactions because cross‑reactivity can reach 10%. 1, 2

Adjunctive Symptomatic Management

• Offer acetaminophen or ibuprofen for moderate‑to‑severe sore throat, fever, or systemic discomfort, as these agents provide effective pain and inflammation control. 1, 2
• Avoid aspirin in this 13‑year‑old patient because of the risk of Reye syndrome in children and adolescents. 1, 2
• Systemic corticosteroids are not recommended as adjunctive therapy for streptococcal pharyngitis, even in the presence of HSP, as they do not prevent rheumatic fever or suppurative complications. 1, 2

Common Pitfalls to Avoid

• Do not withhold or delay antibiotic therapy because of the concurrent HSP diagnosis; the streptococcal infection requires standard treatment regardless of the vasculitis. 3
• Do not shorten the antibiotic course below 10 days (except the 5‑day azithromycin regimen), as this dramatically increases failure and rheumatic‑fever risk. 1, 2
• Do not prescribe trimethoprim‑sulfamethoxazole, as it fails to eradicate Group A Streptococcus in 20–25% of cases. 1
• Do not order routine post‑treatment throat cultures for asymptomatic patients; reserve testing for special circumstances such as a prior history of rheumatic fever. 1, 2

Monitoring Considerations in HSP

• Close follow‑up of renal status is required in all HSP patients, as renal involvement is a component of the disease triad, but this monitoring is independent of antibiotic therapy. 3
• Reassess the patient within 48–72 hours if there is no clinical improvement, as this may indicate non‑compliance, an alternative diagnosis, or a suppurative complication. 1